Herpe, F. V., Bucalau, A., Callebout, E., Eynde, M. V. D., Vandamme, T., Vandecandelaere, P., Wit, M. D., Dumon, K., Chiritescu, G., Deman, F., Salgado, R., Rasschaert, G., Dekervel, J. (2026). Phase II RAINSPOT: A multicentric open label trial of zolbetuximab-paclitaxel-ramucirumab in second-line setting for CLDN18.2-positive gastro-esophageal adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4243